The molecular mechanism of hypertrophic scar

Journal of Cell Communication and Signaling

Volumn 7, Issue 4, 2013, Pages 239-252

  Zhu, Zhensen ^a   Ding, Jie ^a   Shankowsky, Heather A ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytokines; Decorin; Hypertrophic scar; Matrix metalloproteinases; TGF

Indexed keywords

ALPHA2B INTERFERON; CHEMOKINE; DECORIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; SCLEROPROTEIN; SMAD PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

CELL FUNCTION; HUMAN; HYPERTROPHIC SCAR; MOLECULAR PATHOLOGY; MONOCYTE; MYOFIBROBLAST; NONSURGICAL INVASIVE THERAPY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SKIN SURGERY; TH1 CELL; TH2 CELL; TH3 CELL; WOUND HEALING;

EID: 84891371358     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-013-0195-5     Document Type: Review

References (145)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 15;166(12):7556-7562
2. Ahn ST, Monafo WW, Mustoe TA (1989) Topical silicone gel: a new treatment for hypertrophic scars. Surgery 106(4):781-786, discussion 786-7
3. Ali-Bahar M, Bauer B, Tredget EE, Ghahary A (2004) Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 12(2):175-182
4. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 15;116(Pt 2):217-224
5. Anzarut A, Olson J, Singh P, Rowe BH, Tredget EE (2009) The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 62(1):77-84, Epub 2008 Jan 14
6. Armour A, Scott PG, Tredget EE (2007) Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 15(Suppl 1):S6-S17
7. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1(5):260-266
8. Atiyeh BS (2007) Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 31(5):468-492, discussion 493-4. Epub 2007 Jun 18
9. Atiyeh BS, Costagliola M, Hayek SN (2005) Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg 54(6):676-680
10. Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, Weiss ID, Pal B, Wald O, Ad-El D, Fujii N, Arenzana-Seisdedos F, Jung S, Galun E, Gur E, Peled A (2006) Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 126(2):468-476
11. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4(7):540-550
12. Bauer BS, Tredget EE, Marcoux Y, Scott PG, Ghahary A (2002) Latent and active transforming growth factor beta1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system. J Invest Dermatol 119(2):456-463
13. Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U (2005) Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol 85(3):216-220
14. Bombaro KM, Engrav LH, Carrougher GJ, Wiechman SA, Faucher L, Costa BA, Heimbach DM, Rivara FP, Honari S (2003) What is the prevalence of hypertrophic scarring following burns? Burns 29(4):299-302
15. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J (2004) Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 173(3):2099-2108
16. Broekelmann TJ, Limper AH, Colby TV, McDonald JA (1991) Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1;88(15):6642-6646
17. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1(1):71-81
18. Castagnoli C, Stella M, Magliacani G (2002) Role of T-lymphocytes and cytokines in post-burn hypertrophic scars. Wound Repair Regen 10(2):107-108
19. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253(1-2):269-285
20. Chan T, Ghahary A, Demare J, Yang L, Iwashina T, Scott PG, Tredget EE (2002) Development, characterization, and wound healing of the keratin 14 promoted transforming growth factor-beta1 transgenic mouse. Wound Repair Regen 10(3):177-187
21. Chesney J, Bacher M, Bender A, Bucala R (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 10;94(12):6307-6412
22. Choi WT, An J (2011) Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases. Exp Biol Med (Maywood) 236(6):637-647, Epub 2011 May 12
23. Craig MJ, Loberg RD (2006) CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases. Cancer Metastasis Rev 25(4):611-619
24. Cutroneo KR (2007) TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 15(Suppl 1):S54-S60
25. Dang CM, Beanes SR, Lee H, Zhang X, Soo C, Ting K (2003) Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue- derived inhibitor of metalloproteinase ratio. Plast Reconstr Surg 111(7):2273-2285
26. Darzi MA, Chowdri NA, Kaul SK, Khan M (1992) Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 45(5):374-379
27. Das S, Mandal M, Chakraborti T, Mandal A, Chakraborti S (2003) Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol Cell Biochem 253(1-2):31-40
28. Davis PA, Corless DJ, Aspinall R, Wastell C (2001) Effect of CD4(+) and CD8(+) cell depletion on wound healing. Br J Surg 88(2):298-304
29. De Felice B, Garbi C, Santoriello M, Santillo A, Wilson RR (2009) Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts. Mol Cell Biochem 327(1-2):191-201
30. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122(1):103-111
31. Ding J, Hori K, Zhang R, Marcoux Y, Honardoust D, Shankowsky HA, Tredget EE (2011) Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). Wound Repair Regen 19(5):568-578
32. Doucet C, Brouty-Boyé D, Pottin-Clémenceau C, Canonica GW, Jasmin C, Azzarone B (1998) Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 101(10):2129-2139
33. Dunkin CS, Pleat JM, Gillespie PH, Tyler MP, Roberts AH, McGrouther DA (2007) Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 119(6):1722-1732, discussion 1733-4
34. Engrav LH, Garner WL, Tredget EE (2007) Hypertrophic scar, wound contraction and hyper-hypopigmentation. J Burn Care Res 28(4):593-597
35. Eto H, Suga H, Aoi N, Kato H, Doi K, Kuno S, Tabata Y, Yoshimura K (2012) Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression. Lab Invest 92(2):214-223. doi: 10.1038/labinvest.2011.127, Epub 2011 Sep 26
36. Feldman SR, Trojanowska M, Smith EA, Leroy EC (1993) Differential responses of human papillary and reticular fibroblasts to growth factors. Am J Med Sci 305(4):203-207
37. Fernandez EJ, Lolis E (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42:469-499
38. Ferreira AM, Takagawa S, Fresco R, Zhu X, Varga J, DiPietro LA (2006) Diminished induction of skin fibrosis in mice with MCP-1 deficiency. J Invest Dermatol 126(8):1900-1908, Epub 2006 May 11
39. Ghahary A, Shen YJ, Nedelec B, Scott PG, Tredget EE (1995a) Interferons gamma and alpha-2b differentially regulate the expression of collagenase and tissue inhibitor of metalloproteinase-1 messenger RNA in human hypertrophic and normal dermal fibroblasts. Wound Repair Regen 3(2):176-184
40. Ghahary A, Shen YJ, Scott PG, Tredget EE (1995b) Immunolocalization of TGF-beta 1 in human hypertrophic scar and normal dermal tissues. Cytokine 7(2):184-190
41. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE (1996) Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106(3):476-481
42. Ghahary A, Shen Q, Shen YJ, Scott PG, Tredget EE (1998a) Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 174(3):301-309
43. Ghahary A, Tredget EE, Chang LJ, Scott PG, Shen Q (1998b) Genetically modified dermal keratinocytes express high levels of transforming growth factor-beta1. J Invest Dermatol 110(5):800-805
44. Ghahary A, Tredget EE, Mi L, Yang L (1999) Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Exp Cell Res 251(1):111-120
45. Ghahary A, Tredget EE, Shen Q, Kilani RT, Scott PG, Houle Y (2000) Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1-induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts. Growth Factors 17(3):167-176
46. Ghahary A, Tredget EE, Ghahary A, Bahar MA, Telasky C (2002) Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent. Wound Repair Regen 10(5):328-335
47. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M (2005) Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 124(1):170-177
48. Gharaee-Kermani M, Denholm EM, Phan SH (1996) Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271(30):17779-17784
49. Gold MH, Foster TD, Adair MA, Burlison K, Lewis T (2001) Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg 27(7):641-644
50. Hasegawa M, Sato S (2008) The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis. Front Biosci 13:3637-3647
51. Honardoust D, Varkey M, Hori K, Ding J, Shankowsky HA, Tredget EE (2011) Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen 19(3):368-378. doi: 10.1111/j.1524-475X.2011.00677.x, Epub 2011 Apr 21
52. Honardoust D, Ding J, Varkey M, Shankowsky HA, Tredget EE (2012a) Deep Dermal Fibroblasts Refractory to Migration and Decorin-Induced Apoptosis Contribute to Hypertrophic Scarring. J Burn Care Res 2. [Epub ahead of print]
53. Honardoust D, Varkey M, Marcoux Y, Shankowsky HA, Tredget EE (2012b) Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring. J Burn Care Res 33(2):218-227
54. Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM (2007) Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 282(31):22910-22920, Epub 2007 Jun 7
55. Hori K, Ding J, Marcoux Y, Iwashina T, Sakurai H, Tredget EE (2012) Impaired cutaneous wound healing in transforming growth factor-β inducible early gene1 knockout mice. Wound Repair Regen 20(2):166-177. doi: 10.1111/j.1524-475X.2012.00773.x
56. Kilani RT, Delehanty M, Shankowsky HA, Ghahary A, Scott P, Tredget EE (2005) Fluorescent-activated cell-sorting analysis of intracellular interferon-gamma and interleukin-4 in fresh and frozen human peripheral blood T-helper cells. Wound Repair Regen 13(4):441-449
57. Kim BC, Kim HT, Park SH, Cha JS, Yufit T, Kim SJ, Falanga V (2003) Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol 195(3):331-336
58. Klass BR, Grobbelaar AO, Rolfe KJ (2009) Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J 85(999):9-14
59. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, Gauldie J (2001) Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 163(3 Pt 1):770-777
60. Kopp J, Preis E, Said H, Hafemann B, Wickert L, Gressner AM, Pallua N, Dooley S (2005) Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 280(22):21570-21576
61. Kwan P, Hori K, Ding J, Tredget EE (2009) Scar and contracture: biological principles. Hand Clin 25(4):511-528
62. Ladak A, Tredget EE (2009) Pathophysiology and management of the burn scar. Clin Plast Surg 36(4):661-674
63. Lam E, Tredget EE, Marcoux Y, Li Y, Ghahary A (2004) Insulin suppresses collagenase stimulatory effect of stratifin in dermal fibroblasts. Mol Cell Biochem 266(1-2):167-174
64. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A (2005) Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 125(2):230-238
65. Lee KK, Mehrany K, Swanson NA (2005) Surgical revision. Dermatol Clin 23(1):141-150, vii
66. Lee EK, Lee YS, Han IO, Park SH (2007) Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells. Biochem Biophys Res Commun 27;359(2):385-90. Epub 2007 May 25
67. Liao WT, Yu HS, Arbiser JL, Hong CH, Govindarajan B, Chai CY, Shan WJ, Lin YF, Chen GS, Lee CH (2010) Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids. Exp Dermatol 19(8):e142-e150
68. Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Flemming P, Manns MP, Boeker KH (2001) Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J Hepatol 34(2):239-247
69. Liu W, Chua C, Wu X, Wang D, Ying D, Cui L, Cao Y (2005) Inhibiting scar formation in rat wounds by adenovirus-mediated overexpression of truncated TGF-beta receptor II. Plast Reconstr Surg 115(3):860-870
70. Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA (2005) The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201(3):391-397
71. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W, Roers A, Eming SA (2010) Differential roles of macrophages in diverse phases of skin repair. J Immunol 1;184(7):3964-77. doi: 10.4049/jimmunol.0903356. Epub 2010 Feb 22
72. Macintyre L, Baird M (2006) Pressure garments for use in the treatment of hypertrophic scars-a review of the problems associated with their use. Burns 32(1):10-15
73. Manuel JA, Gawronska-Kozak B (2006) Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice. Matrix Biol 25(8):505-514, Epub 2006 Aug 16
74. Massagué J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753-791
75. McDougall S, Dallon J, Sherratt J, Maini P (2006) Fibroblast migration and collagen deposition during dermal wound healing: mathematical modelling and clinical implications. Philos Transact A Math Phys Eng Sci 15;364(1843):1385- 1405
76. McGee GS, Broadley KN, Buckley A, Aquino A, Woodward SC, Demetriou AA, Davidson JM (1989) Recombinant transforming growth factor beta accelerates incisional wound healing. Curr Surg 46(2):103-106
77. Metz CN (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60(7):1342-1350
78. Miller MC, Nanchahal J (2005) Advances in the modulation of cutaneous wound healing and scarring. BioDrugs 19(6):363-381
79. Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V, Legrand E, Vannier J, Soria J, Vasse M, Soria C (2000) SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res 15;99(6):587-594
80. Momeni M, Hafezi F, Rahbar H, Karimi H (2009) Effects of silicone gel on burn scars. Burns 35(1):70-74, Epub 2008 Jul 30
81. Monstrey S, Hoeksema H, Verbelen J, Pirayesh A, Blondeel P (2008) Assessment of burn depth and burn wound healing potential. Burns 34(6):761-769, Epub 2008 Jun 3
82. Monteleone G, Pallone F, MacDonald TT (2004) Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol 25(10):513-517
83. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304(1):81-90, Epub 2004 Dec 8
84. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
85. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Vallé CA, Roy M (2004) Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198(3):350-358
86. Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118(Pt 16):3573-3584
87. Murray LA, Chen Q, Kramer MS, Hesson DP, Argentieri RL, Peng X, Gulati M, Homer RJ, Russell T, van Rooijen N, Elias JA, Hogaboam CM, Herzog EL (2011) TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 43(1):154-162. doi: 10.1016/j.biocel.2010.10. 013, Epub 2010 Oct 29
88. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE (2002) International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 110(2):560-571
89. Nagasawa T (2001) Role of chemokine SDF-1/PBSF and its receptor CXCR4 in blood vessel development. Ann N Y Acad Sci 947:112-115, discussion 115-6
90. Nedelec B, Shen YJ, Ghahary A, Scott PG, Tredget EE (1995) The effect of interferon alpha 2b on the expression of cytoskeletal proteins in an in vitro model of wound contraction. J Lab Clin Med 126(5):474-484
91. Nedelec B, Ghahary A, Scott PG, Tredget EE (2000) Control of wound contraction. Basic and clinical features. Hand Clin 16(2):289-302
92. Nedelec B, Shankowsky H, Scott PG, Ghahary A, Tredget EE (2001) Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery 130(5):798-808
93. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222(4):482-490, discussion 490-2
94. Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M (2007) Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem 282(14):10405-10413
95. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36(4):598-606
96. Reinke JM, Sorg H (2012) Wound Repair and Regeneration. Eur Surg Res 11;49(1):35-43
97. Reynolds JJ (1996) Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 2(1):70-76
98. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH et al (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83(12):4167-4171
99. Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg FT Jr, Hobson RW 2nd, Durán WN, Pappas PJ (2001) Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg 34(5):930-938
100. Sarkhosh K, Tredget EE, Karami A, Uludag H, Iwashina T, Kilani RT, Ghahary A (2003) Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J Cell Biochem 90(1):206-217
101. Sawicki G, Marcoux Y, Sarkhosh K, Tredget EE, Ghahary A (2005) Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem 269(1-2):209-216
102. Sayani K, Dodd CM, Nedelec B, Shen YJ, Ghahary A, Tredget EE, Scott PG (2000) Delayed appearance of decorin in healing burn scars. Histopathology 36(3):262-272
103. Schönherr E, Hausser HJ (2000) Extracellular matrix and cytokines: a functional unit. Dev Immunol 7(2-4):89-101
104. Scott PG, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F (1995) Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars. Histopathology 26(5):423-431
105. Scott PG, Ghahary A, Tredget EE (2000) Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16(2):271-287
106. Shah M, Foreman DM, Ferguson MW (1994) Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107(Pt 5):1137-1157
107. Shah M, Foreman DM, Ferguson MW (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108(Pt 3):985-1002
108. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A (2006) CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 21;281(16):10715-10726. Epub 2006 Feb 16
109. Sidgwick GP, Bayat A (2012) Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 26(2):141-152
110. Simon F, Bergeron D, Larochelle S, Lopez-Vallé CA, Genest H, Armour A, Moulin VJ (2012) Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis. Burns 38(3):421-427, Epub 2011 Oct 29
111. Sorrell JM, Caplan AI (2004) Fibroblast heterogeneity: more than skin deep. J Cell Sci 117(Pt 5):667-675
112. Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200(4):448-464
113. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, Dooley S (2000) Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem 275(38):29308-29317
114. Tanriverdi-Akhisaroglu S, Menderes A, Oktay G (2009) Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study. Cell Biochem Funct 27(2):81-87
115. Tredget EE (1999) Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann N Y Acad Sci 888:165-182
116. Tredget EE, Nedelec B, Scott PG, Ghahary A (1997) Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77(3):701-730
117. Tredget EE, Shankowsky HA, Pannu R, Nedelec B, Iwashina T, Ghahary A, Taerum TV, Scott PG (1998) Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 102(5):1317-1328, discussion 1329-30
118. Tredget EE, Wang R, Shen Q, Scott PG, Ghahary A (2000) Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 20(2):143-151
119. Tredget EE, Yang L, Delehanty M, Shankowsky H, Scott PG (2006) Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 26(3):179-189
120. Ulrich D, Noah EM, von Heimburg D, Pallua N (2003) TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg 1;111(4):1423-1431
121. Vaalamo M, Leivo T, Saarialho-Kere U (1999) Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 30(7):795-802
122. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE (1996) Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 106(3):419-427
123. Wang R, Ghahary A, Shen Q, Scott PG, Roy K, Tredget EE (2000) Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 8(2):128-137
124. Wang B, Hao J, Jones SC, Yee MS, Roth JC, Dixon IM (2002) Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am J Physiol Heart Circ Physiol 282(5):H1685-H1696
125. Wang J, Jiao H, Stewart TL, Lyons MV, Shankowsky HA, Scott PG, Tredget EE (2007a) Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol 82(6):1554-1563
126. Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE (2007b) Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 15(1):113-121
127. Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE (2007c) Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen 15(4):530-539
128. Wang J, Chen H, Shankowsky HA, Scott PG, Tredget EE (2008a) Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res 28(7):423-434
129. Wang J, Dodd C, Shankowsky HA, Scott PG, Tredget EE, Wound Healing Research Group (2008b) Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88(12):1278-1290, Epub 2008 Oct 27
130. Wang J, Ding J, Jiao H, Honardoust D, Momtazi M, Shankowsky HA, Tredget EE (2011a) Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen 19(2):274-285
131. Wang J, Hori K, Ding J, Huang Y, Kwan P, Ladak A, Tredget EE (2011b) Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 226(5):1265-1273. doi: 10.1002/jcp.22454
132. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83(3):835-870
133. Wynn TA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4(8):583-594
134. Xie JL, Bian HN, Qi SH, Chen HD, Li HD, Xu YB, Li TZ, Liu XS, Liang HZ, Xin BR, Huan Y (2008) Basic fibroblast growth factor (bFGF) alleviates the scar of the rabbit ear model in wound healing. Wound Repair Regen 16(4):576-581
135. Xu LL, Warren MK, Rose WL, Gong W, Wang JM (1996) Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol 60(3):365-371
136. Xu SW, Howat SL, Renzoni EA, Holmes A, Pearson JD, Dashwood MR, Bou-Gharios G, Denton CP, du Bois RM, Black CM, Leask A, Abraham DJ (2004) Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem 28;279(22):23098-23103
137. Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M (2007) Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol 37(3):291-299, Epub 2007 Apr 26
138. Yang L, Tredget EE, Ghahary A (2000) Activation of latent transforming growth factor-beta1 is induced by mannose 6-phosphate/insulin-like growth factor-II receptor. Wound Repair Regen 8(6):538-546
139. Yang L, Chan T, Demare J, Iwashina T, Ghahary A, Scott PG, Tredget EE (2001) Healing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermis. Am J Pathol 159(6):2147-2157
140. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE (2002) Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82(9):1183-1192
141. Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, Ghahary A, Tredget EE (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13(4):398-404
142. Yuan W, Varga J (2001) Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 19;276(42):38502-38510. Epub 2001 Aug 13
143. Zhang GY, He B, Liao T, Luan Q, Tao C, Nie CL, Albers AE, Zheng X, Xie XG, Gao WY (2011a) Caveolin 1 inhibits transforming growth factor-β1 activity via inhibition of Smad signaling by hypertrophic scar derived fibroblasts in vitro. J Dermatol Sci 62(2):128-131, Epub 2011 Feb 24
144. Zhang ZF, Zhang YG, Hu DH, Shi JH, Liu JQ, Zhao ZT, Wang HT, Bai XZ, Cai WX, Zhu HY, Tang CW (2011b) Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Burns 37(4):665-672, Epub 2011 Jan 14
145. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393(6685):595-599